Search results for "nephrology"

showing 10 items of 673 documents

The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trial

2019

Abstract Background The Artificial Kidney Initiation in Kidney Injury (AKIKI) trial showed that a delayed renal replacement therapy (RRT) strategy for severe acute kidney injury (AKI) in critically ill patients was safe and associated with major reduction in RRT initiation compared with an early strategy. The five criteria which mandated RRT initiation in the delayed arm were: severe hyperkalemia, severe acidosis, acute pulmonary edema due to fluid overload resulting in severe hypoxemia, serum urea concentration > 40 mmol/l and oliguria/anuria > 72 h. However, duration of anuria/oliguria and level of blood urea are still criteria open to debate. The objective of the study is to compar…

Time FactorsHyperkalemiamedicine.medical_treatment[SDV]Life Sciences [q-bio]Medicine (miscellaneous)030204 cardiovascular system & hematologyKidneyurologic and male genital diseases[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrologylaw.inventionTime-to-Treatment03 medical and health sciencesStudy Protocol0302 clinical medicineRandomized controlled triallawOliguriamedicineHumansMulticenter Studies as TopicPharmacology (medical)030212 general & internal medicineRenal replacement therapyProspective StudiesTreatment outcomeRandomized Controlled Trials as TopicMechanical ventilationlcsh:R5-920business.industryRenal replacement therapyAcute kidney injuryRecovery of FunctionInterim analysismedicine.diseasefemale genital diseases and pregnancy complications3. Good healthAcute kidney injuryCritical careAnesthesiaAnuria[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFrancemedicine.symptombusinesslcsh:Medicine (General)Kidneys Artificial
researchProduct

Long-term Challenges After Solid Organ Transplantation

2018

Transplantation03 medical and health sciencesTransplantationmedicine.medical_specialty0302 clinical medicinebusiness.industry030232 urology & nephrologymedicine030230 surgeryIntensive care medicineSolid organ transplantationbusinessTerm (time)Transplantation
researchProduct

P1055REMARKABLE REMOVALS OF BETA-2-MICROGLOBULIN AND PHOSPHATE WITH SHORT-DAILY HOME HEMODIALYSIS USING LOW DIALYSATE FLOW RATE

2020

Abstract Background and Aims Short-daily hemodialysis (HD) with low-dialysate volume is an appealing portable dialysis approach for home use. Although this type of HD has proved being effective for the volume control and the clearance of low molecular-weight uremic toxins, limited data are available on the impact on the removal rates of other uremic toxins like β2-microglobulin (β2M) or phosphate (P), whose clearance is limited by sequestration into compartments, poor diffusion, high time-dependency, or protein binding. We evaluated the impact of short-daily HD with slow dialysate flow rate on the removal of solutes of different molecular weights and distribution volumes. Method Single-sess…

TransplantationCreatininemedicine.medical_specialtyBeta-2 microglobulinbusiness.industryHome hemodialysismedicine.medical_treatmentUrologyDialysate flowPhosphatechemistry.chemical_compoundDialysis solutionschemistryNephrologymedicineHemodialysisbusinessClearanceNephrology Dialysis Transplantation
researchProduct

FP749The effect of short daily home hemodialysis with low-flow, lactate-buffered dialysate on nutritional status and body composition

2019

TransplantationDialysis solutionsAnimal scienceFlow (mathematics)Nephrologybusiness.industryHome hemodialysisMedicineComposition (visual arts)Nutritional statusbusinessNephrology Dialysis Transplantation
researchProduct

FP187MITOCHONDRIAL DYSFUNCTION INDUCED BY TENOFOVIR IN RENAL CELLS. POTENTIATION OF THE EFFECTS BY CO-STIMULATION WITH ANGIOTENSIN II

2015

TransplantationKidneyAngiotensin receptorTenofovirbusiness.industryLong-term potentiationMitochondrionPharmacologyAngiotensin IImedicine.anatomical_structureCo-stimulationNephrologyLymphocyte costimulationMedicinebusinessmedicine.drugNephrology Dialysis Transplantation
researchProduct

Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study

1995

It was found that in Belgium, renal imaging techniques, demonstrating a decreased renal mass of both kidneys combined with either bumpy contours or papillary calcifications, were the only methods to reliably diagnose analgesic nephropathy (AN) in patients with end-stage renal failure. However, these criteria were selected in an area with a high prevalence of this disease (15.6% of the dialysis population at December 1990). To evaluate the criteria selected to diagnose AN in populations with lower or unknown prevalences of AN, the Analgesic Nephropathy Network of Europe (ANNE) was formed, consisting of 23 dialysis units from 14 European countries and Brazil. During 1991-1992, 598 new patient…

TransplantationKidneymedicine.medical_specialtyeducation.field_of_studybusiness.industrymedicine.medical_treatmentPopulationmedicine.diseaseAnalgesic nephropathyNephropathySurgeryDiabetic nephropathymedicine.anatomical_structureNephrologymedicineRadiologyHemodialysisRenal replacement therapyeducationbusinessDialysisNephrology Dialysis Transplantation
researchProduct

Genetic predisposition—is lupus nephritis a question of copy numbers?**Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats an…

2006

TransplantationNephrologybusiness.industryImmunologyGenetic predispositionLupus nephritisMedicinebusinessmedicine.diseaseNephrology Dialysis Transplantation
researchProduct

Acanthocytes in urinary sediment--a pathognomonic marker?

1998

TransplantationPathologymedicine.medical_specialtyRenal glomerulusbusiness.industryKidney GlomerulusEchinocyteNephrologyUrinary sedimentPathognomonicErythrocyte DeformabilitymedicineHumansbusinessAcanthocyteHematuriaNephrology Dialysis Transplantation
researchProduct

Acanthocyturia detects glomerular bleeding.

1993

TransplantationPathologymedicine.medical_specialtybusiness.industryPhase contrast microscopyKidney GlomerulusAcanthocytesHemorrhagelaw.inventionText miningNephrologylawMedicineHumansKidney DiseasesbusinessHematuriaNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

Fabry nephropathy: 5 years of enzyme replacement therapy-a short review.

2007

Fabry disease is an X-linked lysosomal storage disease, resulting from a deficiency of the enzyme α-galactosidase A and subsequent cellular storage of the enzyme substrate globotriaosylceramide (Gb3) [1]. Estimates of the incidence of Fabry disease vary markedly, from 1:<5000 male births in a newborn screening study in Italy [2] to 1:117 000 male births in Australia [3] and 1:833 000 male births in northern Portugal [4]. In general, hemizygous males are more severely affected than heterozygous females. In males, life expectancy is reduced by an average of 20 years [5] and in females by 15 years [6]. Although males tend to suffer symptoms earlier than females, both boys and girls can be affe…

TransplantationPediatricsmedicine.medical_specialtyNewborn screeningFabry diseasekidneyACE inhibitorsbusiness.industryGlobotriaosylceramideEnzyme replacement therapymedicine.diseaseFabry diseaseNephropathyTransplantationangiotensin receptor blockerschemistry.chemical_compoundchemistryNephrologymedicineLysosomal storage diseasenephropathyIn-Depth Clinical ReviewbusinessCause of deathenzyme replacement therapyNDT plus
researchProduct